Omesar (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Omesar, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adult patients. GNH USA supplies Omesar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omesar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omesar is an ARB that lowers blood pressure by interfering with the renin‑angiotensin‑aldosterone system.

- Hypertension: helps reduce systolic and diastolic blood pressure in adults. - Heart failure: used as part of combination therapy to improve cardiac output and reduce hospitalisation risk. - Diabetic nephropathy : slows the progression of kidney damage in patients with type 2 diabetes.